ADAPTIVE BIOTECHNOLOGIES COR
ADPT·00650F109·US·Common Stock·Healthcare - Biotechnology-13D/G
ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is held by 154 institutional investors as of Q1 2026. Largest holders: VIKING GLOBAL INVESTORS LP ($416.3M), BlackRock, Inc. ($184.6M), VANGUARD CAPITAL MANAGEMENT LLC ($84.6M). Net institutional sentiment: Mixed.
154
Holders
(12 Elite)
$1.8B
Total Value
56% (147)
Consensus
83 buying - 64 selling
13F: Insider & Congress:
Who's Trading
InsiderRSROBINS HARLAN SSell $5.2MJul 2, 2026
InsiderRSROBINS HARLAN SSell $3.3MJul 2, 2026
InsiderBSBENZENO SHARONSell $3.3MJun 29, 2026
InsiderBSBENZENO SHARONSell $232KJun 26, 2026
InsiderBSBOBULSKY SUSANSell $103KJun 25, 2026
InsiderRJRUBINSTEIN JULIEExercise 15K shApr 27, 2026
InsiderRJRUBINSTEIN JULIESell $271KApr 27, 2026
InsiderRJRUBINSTEIN JULIEExercise 15K shApr 24, 2026
Showing 1-20 of 160
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer